Selected research
Industry Research
Cefquinome Sulfate Injection Industry Research Report 2026
Market perspective
The global Cefquinome Sulfate Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cefquinome Sulfate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cefquinome Sulfate Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cefquinome Sulfate Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cefquinome Sulfate Injection include Wuhan Huisheng Biological Technology Co., Ltd., Qilu Animal Health Products Co., Ltd., Jiangxi Chuangxin Pharmaceutical Group Co., Ltd., Jiangxi Chengbixin Biological Technology Co., Ltd., Hebei Tianyuan Pharmaceutical Co., Ltd., MSD Animal Health, Boviso Animal Health and AdvaCare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cefquinome Sulfate Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cefquinome Sulfate Injection Market by Company
Wuhan Huisheng Biological Technology Co., Ltd.
Qilu Animal Health Products Co., Ltd.
Jiangxi Chuangxin Pharmaceutical Group Co., Ltd.
Jiangxi Chengbixin Biological Technology Co., Ltd.
Hebei Tianyuan Pharmaceutical Co., Ltd.
MSD Animal Health
Boviso Animal Health
AdvaCare
Cefquinome Sulfate Injection Segment by Type
10ml/ Bottle
100ml/ Bottle
Cefquinome Sulfate Injection Segment by Application
Cow High Fever
Cow Pneumonia
Others
Cefquinome Sulfate Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cefquinome Sulfate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cefquinome Sulfate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cefquinome Sulfate Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cefquinome Sulfate Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cefquinome Sulfate Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cefquinome Sulfate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10ml/ Bottle
- 100ml/ Bottle
Applications
- Cow High Fever
- Cow Pneumonia
- Others
Companies covered
- Wuhan Huisheng Biological Technology Co., Ltd.
- Qilu Animal Health Products Co., Ltd.
- Jiangxi Chuangxin Pharmaceutical Group Co., Ltd.
- Jiangxi Chengbixin Biological Technology Co., Ltd.
- Hebei Tianyuan Pharmaceutical Co., Ltd.
- MSD Animal Health
- Boviso Animal Health
- AdvaCare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cefquinome Sulfate Injection Market Size (2021-2032)
- 2.2.2 Global Cefquinome Sulfate Injection Sales (2021-2032)
- 2.2.3 Global Cefquinome Sulfate Injection Market Average Price (2021-2032)
- 2.3 Cefquinome Sulfate Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10ml/ Bottle
- 2.3.3 100ml/ Bottle
- 2.4 Cefquinome Sulfate Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cow High Fever
- 2.4.3 Cow Pneumonia
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cefquinome Sulfate Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cefquinome Sulfate Injection Sales (K Doses) of Manufacturers (2021-2026)
- 3.3 Global Cefquinome Sulfate Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Cefquinome Sulfate Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Cefquinome Sulfate Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cefquinome Sulfate Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cefquinome Sulfate Injection, Product Type & Application
- 3.8 Global Manufacturers of Cefquinome Sulfate Injection, Established Date
- 3.9 Global Cefquinome Sulfate Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wuhan Huisheng Biological Technology Co., Ltd.
- 4.1.1 Wuhan Huisheng Biological Technology Co., Ltd. Company Information
- 4.1.2 Wuhan Huisheng Biological Technology Co., Ltd. Business Overview
- 4.1.3 Wuhan Huisheng Biological Technology Co., Ltd. Cefquinome Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Wuhan Huisheng Biological Technology Co., Ltd. Cefquinome Sulfate Injection Product Portfolio
- 4.1.5 Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments
- 4.2 Qilu Animal Health Products Co., Ltd.
- 4.2.1 Qilu Animal Health Products Co., Ltd. Company Information
- 4.2.2 Qilu Animal Health Products Co., Ltd. Business Overview
- 4.2.3 Qilu Animal Health Products Co., Ltd. Cefquinome Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Qilu Animal Health Products Co., Ltd. Cefquinome Sulfate Injection Product Portfolio
- 4.2.5 Qilu Animal Health Products Co., Ltd. Recent Developments
- 4.3 Jiangxi Chuangxin Pharmaceutical Group Co., Ltd.
- 4.3.1 Jiangxi Chuangxin Pharmaceutical Group Co., Ltd. Company Information
- 4.3.2 Jiangxi Chuangxin Pharmaceutical Group Co., Ltd. Business Overview
- 4.3.3 Jiangxi Chuangxin Pharmaceutical Group Co., Ltd. Cefquinome Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangxi Chuangxin Pharmaceutical Group Co., Ltd. Cefquinome Sulfate Injection Product Portfolio
- 4.3.5 Jiangxi Chuangxin Pharmaceutical Group Co., Ltd. Recent Developments
- 4.4 Jiangxi Chengbixin Biological Technology Co., Ltd.
- 4.4.1 Jiangxi Chengbixin Biological Technology Co., Ltd. Company Information
- 4.4.2 Jiangxi Chengbixin Biological Technology Co., Ltd. Business Overview
- 4.4.3 Jiangxi Chengbixin Biological Technology Co., Ltd. Cefquinome Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jiangxi Chengbixin Biological Technology Co., Ltd. Cefquinome Sulfate Injection Product Portfolio
- 4.4.5 Jiangxi Chengbixin Biological Technology Co., Ltd. Recent Developments
- 4.5 Hebei Tianyuan Pharmaceutical Co., Ltd.
- 4.5.1 Hebei Tianyuan Pharmaceutical Co., Ltd. Company Information
- 4.5.2 Hebei Tianyuan Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 Hebei Tianyuan Pharmaceutical Co., Ltd. Cefquinome Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hebei Tianyuan Pharmaceutical Co., Ltd. Cefquinome Sulfate Injection Product Portfolio
- 4.5.5 Hebei Tianyuan Pharmaceutical Co., Ltd. Recent Developments
- 4.6 MSD Animal Health
- 4.6.1 MSD Animal Health Company Information
- 4.6.2 MSD Animal Health Business Overview
- 4.6.3 MSD Animal Health Cefquinome Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 MSD Animal Health Cefquinome Sulfate Injection Product Portfolio
- 4.6.5 MSD Animal Health Recent Developments
- 4.7 Boviso Animal Health
- 4.7.1 Boviso Animal Health Company Information
- 4.7.2 Boviso Animal Health Business Overview
- 4.7.3 Boviso Animal Health Cefquinome Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Boviso Animal Health Cefquinome Sulfate Injection Product Portfolio
- 4.7.5 Boviso Animal Health Recent Developments
- 4.8 AdvaCare
- 4.8.1 AdvaCare Company Information
- 4.8.2 AdvaCare Business Overview
- 4.8.3 AdvaCare Cefquinome Sulfate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 AdvaCare Cefquinome Sulfate Injection Product Portfolio
- 4.8.5 AdvaCare Recent Developments
5 Global Cefquinome Sulfate Injection Market Scenario by Region
- 5.1 Global Cefquinome Sulfate Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cefquinome Sulfate Injection Sales by Region: 2021-2032
- 5.2.1 Global Cefquinome Sulfate Injection Sales by Region: 2021-2026
- 5.2.2 Global Cefquinome Sulfate Injection Sales by Region: 2027-2032
- 5.3 Global Cefquinome Sulfate Injection Revenue by Region: 2021-2032
- 5.3.1 Global Cefquinome Sulfate Injection Revenue by Region: 2021-2026
- 5.3.2 Global Cefquinome Sulfate Injection Revenue by Region: 2027-2032
- 5.4 North America Cefquinome Sulfate Injection Market Facts & Figures by Country
- 5.4.1 North America Cefquinome Sulfate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cefquinome Sulfate Injection Sales by Country (2021-2032)
- 5.4.3 North America Cefquinome Sulfate Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Cefquinome Sulfate Injection Market Facts & Figures by Country
- 5.5.1 Europe Cefquinome Sulfate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cefquinome Sulfate Injection Sales by Country (2021-2032)
- 5.5.3 Europe Cefquinome Sulfate Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Cefquinome Sulfate Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cefquinome Sulfate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cefquinome Sulfate Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cefquinome Sulfate Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cefquinome Sulfate Injection Market Facts & Figures by Country
- 5.7.1 South America Cefquinome Sulfate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cefquinome Sulfate Injection Sales by Country (2021-2032)
- 5.7.3 South America Cefquinome Sulfate Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Cefquinome Sulfate Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cefquinome Sulfate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cefquinome Sulfate Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cefquinome Sulfate Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Cefquinome Sulfate Injection Sales by Type (2021-2032)
- 6.1.1 Global Cefquinome Sulfate Injection Sales by Type (2021-2032) & (K Doses)
- 6.1.2 Global Cefquinome Sulfate Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Cefquinome Sulfate Injection Revenue by Type (2021-2032)
- 6.2.1 Global Cefquinome Sulfate Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cefquinome Sulfate Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Cefquinome Sulfate Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cefquinome Sulfate Injection Sales by Application (2021-2032)
- 7.1.1 Global Cefquinome Sulfate Injection Sales by Application (2021-2032) & (K Doses)
- 7.1.2 Global Cefquinome Sulfate Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Cefquinome Sulfate Injection Revenue by Application (2021-2032)
- 7.2.1 Global Cefquinome Sulfate Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cefquinome Sulfate Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Cefquinome Sulfate Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cefquinome Sulfate Injection Value Chain Analysis
- 8.1.1 Cefquinome Sulfate Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cefquinome Sulfate Injection Production Mode & Process
- 8.2 Cefquinome Sulfate Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cefquinome Sulfate Injection Distributors
- 8.2.3 Cefquinome Sulfate Injection Customers
9 Global Cefquinome Sulfate Injection Analyzing Market Dynamics
- 9.1 Cefquinome Sulfate Injection Industry Trends
- 9.2 Cefquinome Sulfate Injection Industry Drivers
- 9.3 Cefquinome Sulfate Injection Industry Opportunities and Challenges
- 9.4 Cefquinome Sulfate Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst